24 Nov 2016
AFT H1 loss in line with expectations
The drug maker, AFT Pharmaceuticals, has reported an increased first half loss, in line with expectations, as it spent more on marketing and research and development.
Recent stories from Business News
Get the RNZ app
for easy access to all your favourite programmes
